CLASS II Device recall · Reported 31 Jul 2019 · FDA Enforcement Report

PulsioFlex Monitoring System recalled by Getinge Us Sales

Getinge US Sales is recalling PulsioFlex Monitoring System, distributed nationwide in the US. The recall was initiated on 5 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codessoftware version:V5.1.0.7 US ver. A., Serial number affected: K17400011005 , K17400011065, K17400011082, K17400011086, K17400011097, K17400011107, L17400011267.
Quantity recalled7

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2077-2019
FDA event ID
83233
Recalling firm
Getinge US Sales, WAYNE, NJ
Classification
Class II
Status
Terminated
Recall initiated
5 Jun 2019
FDA classified
25 Jul 2019
Reported
31 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

5 Jun 2019Recall initiated by company
25 Jul 2019Classified by FDA+50 days
31 Jul 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The monitor displays an error message . The error message states "internal error restart or service".

Product as listed by the FDA

PulsioFlex Monitoring System, Part Number: 6882747, Model Number: PC400 3 R0. Usage: The PulsioFlex Monitoring System is indicated in patients where cardiovascular and circulatory volume status monitoring is necessary. If a patient s biometric data are entered, the PulsioFlex Monitor presents the derived parameters indexed. ¿ -With the PiCCO Module cardiac output is determined both continuously through pulse contour analysis and intermittently through thermodilution technique. Both are used for the determination of other derived parameters. -With the CeVOX oximetry module connected to a compatible oximetry probe, the PulsioFlex Monitoring System measures continuous venous oxygen saturation to assess oxygen delivery and consumption. The use of the PulsioFlex Monitoring System is indicated in patients where cardiovascular and organ monitoring is useful. This includes patients in surgical, medical, and other hospital units

Where it was distributed

US Nationwide distribution in the states of MD, OK, NY,FL, SC

Nationwide FloridaMarylandNew YorkOklahomaSouth Carolina

Questions about this recall

Why was it recalled?

The monitor displays an error message . The error message states "internal error restart or service".

Which lots are affected?

software version:V5.1.0.7 US ver. A., Serial number affected: K17400011005 , K17400011065, K17400011082, K17400011086, K17400011097, K17400011107, L17400011267.

Where was it sold?

US Nationwide distribution in the states of MD, OK, NY,FL, SC

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Getinge US Sales

All 12

Other Heart & Vascular Devices recalls

All 6,199